Drug Profile
Research programme: male infertility therapy - Enhance Biotech
Alternative Names: BIO 316; BIO 317Latest Information Update: 08 Jun 2010
Price :
$50
*
At a glance
- Originator Enhance Biotech
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Male infertility
Most Recent Events
- 08 Jun 2010 Development discontinued for Male infertility during 2006
- 28 Oct 2005 Preclinical trials in Male infertility in USA (unspecified route)